3Rutkowski P,Nowecki Z,Nyckowski P,et al.Surgical treatment of patients (pts) with gastrointestinal stromal tumors (GIST) after imatinib mesylate (IM) therapy[C].ASCO Annual Meeting Process,2005,23:9037.
4Demetri GD,von Mehren M,Blanke C,et al.Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors[J].N Engl J Med,2002,347(7):472-480.
5Denatteo RP,Antonessu W,Chadaram YU,et al.Adjuvant imatinib mesylate in patients with primary high risk gastrointestinal stromal tumor (GIST) following complete resection:Safety results from the U.S.Intergroup Phase Ⅱ trial ACOSOG Z9000[C].ASCO Annual Meeting Process,2005,23:9009.
6FLETCHER C D,BERMEN J J,CORLESS C,et al. Diagnosis of gastrointestinal stromal tumors, a consensus approach [J]. Human Pathol,2002,33(5):459-465.
7RUBIN B P. Gastrointestinal stromal tumours: an update[J]. Histopathology, 2006,48 (1) : 83-96.
8DEMATTEO R P,LEWIS J J,LEUNG D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival[J]. Ann Surg, 2000,231 (1) : 51-58.
9MIETTINEN M, SOBIN L H, LASOTA J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with longterm follow-up[J]. Am J Surg Pathoi,2005,29 (1) : 52-68.
10DAUM O,KLECKA J,FERDA J,et al. Gastrointestinal stromal tumor of the pancreas: case report with documentation of KIT gene mutation[J]. Virchows Arch,2005,446(4):470-472.
